William D. Young's most recent trade in Praxis Precision Medicines Inc was a trade of 10,520 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines... | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 10,520 | 10,520 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,566 | 8,566 | - | - | Stock Option (Right to Buy) | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 41,133 | 102,684 (0%) | 0% | 0 | Common Stock | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 41,133 | 0 | - | - | Restricted Stock Units | |
| Nanostring Technologies Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 41,133 | 41,133 | - | - | Restricted Stock Units | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2023 | 14,851 | 61,551 (0%) | 0% | 0 | Common Stock | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2023 | 14,851 | 0 | - | - | Restricted Stock Units | |
| Praxis Precision Medicines... | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 28,981 | 28,981 | - | - | Stock Option (Right to Buy) | |
| Nanostring Technologies Inc | William D. Young | Director | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 24 May 2023 | 35,400 | 46,700 (0%) | 0% | 5.7 | 201,511 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 14,851 | 14,851 | - | - | Restricted Stock Units | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 3,890 | 0 | - | - | Restricted Stock Units | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 3,890 | 11,300 (0%) | 0% | 0 | Common Stock | |
| Praxis Precision Medicines... | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 22,753 | 22,753 | - | - | Stock Option (Right to Buy) | |
| Theravance Biopharma Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 28,000 | 28,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 9,852 | 78,010 (0%) | 0% | 0 | Ordinary Shares | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2022 | 20,343 | 0 | - | - | Stock Option (right to buy) | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.92 per share. | 24 Feb 2022 | 20,343 | 27,753 (0%) | 0% | 1.9 | 39,059 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 31.71 per share. | 24 Feb 2022 | 8,498 | 16,739 (0%) | 0% | 31.7 | 269,472 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 32.40 per share. | 24 Feb 2022 | 4,273 | 12,466 (0%) | 0% | 32.4 | 138,445 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 33.61 per share. | 24 Feb 2022 | 3,643 | 8,823 (0%) | 0% | 33.6 | 122,441 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 30.68 per share. | 24 Feb 2022 | 1,716 | 25,237 (0%) | 0% | 30.7 | 52,647 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 34.18 per share. | 24 Feb 2022 | 1,413 | 7,410 (0%) | 0% | 34.2 | 48,296 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 29.66 per share. | 24 Feb 2022 | 800 | 26,953 (0%) | 0% | 29.7 | 23,728 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 70.19 per share. | 28 Jun 2021 | 400 | 7,410 (0%) | 0% | 70.2 | 28,076 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.92 per share. | 28 Jun 2021 | 400 | 7,810 (0%) | 0% | 1.9 | 768 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 400 | 20,343 | - | - | Stock Option (right to buy) | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.92 per share. | 28 Jun 2021 | 100 | 7,510 (0%) | 0% | 1.9 | 192 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 28 Jun 2021 | 100 | 7,410 (0%) | 0% | 70 | 7,000 | Common Stock |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 100 | 20,743 | - | - | Stock Option (right to buy) | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 5,520 | 0 | - | - | Common Stock | |
| Nanostring Technologies Inc | William D. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 5,520 | 7,410 (0%) | 0% | - | Common Stock | |
| Nanostring Technologies Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,890 | 3,890 | - | - | Common Stock | |
| Praxis Precision Medicines... | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 22,343 | 22,343 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | William D. Young | Director | Other type of transaction at price $ 0.00 per share. | 13 May 2021 | 28,473 | 28,473 | - | 0 | Common Stock | |
| Theravance Biopharma Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 68,158 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | William D. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) | |
| Nanostring Technologies Inc | William D. Young | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Sep 2020 | 30,000 | 0 (0%) | 0% | 0 | Common Stock |